| Source HCPCS Code |
|
Target NDC Code |
Q5101
INJECTION, FILGRASTIM-SNDZ, BIOSIMILAR, (ZARXIO), 1 MICROGRAM
|
⇄
|
61314-0304-01
ZARXIO (PF) 300 MCG/0.5 ML
|
| Detail Information |
| Relationship Start Date |
04/01/2018 |
| Relationship End Date |
02/28/2021 |
| Number Of Items In Ndc Package |
0.5 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SR |
| Route Of Administration |
IJ |
| Billing Units |
ML |
|
|
|
Q5101
INJECTION, FILGRASTIM-SNDZ, BIOSIMILAR, (ZARXIO), 1 MICROGRAM
|
⇄
|
61314-0318-01
ZARXIO (PF) 300 MCG/0.5 ML
|
| Detail Information |
| Relationship Start Date |
05/04/2018 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
0.5 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SR |
| Route Of Administration |
IJ |
| Billing Units |
ML |
|
|
|
Q5101
Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram
|
⇄
|
61314-0318-05
ZARXIO 300 MCG/0.5 ML SYRINGE
|
| Detail Information |
| Relationship Start Date |
01/01/2025 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
0.5 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SYRINGE |
| Route Of Administration |
IJ |
| Billing Units |
ML |
|
|
|
Q5101
INJECTION, FILGRASTIM-SNDZ, BIOSIMILAR, (ZARXIO), 1 MICROGRAM
|
⇄
|
61314-0318-10
ZARXIO (PF) 300 MCG/0.5 ML
|
| Detail Information |
| Relationship Start Date |
07/20/2018 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
0.5 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SR |
| Route Of Administration |
IJ |
| Billing Units |
ML |
|
|
|
Q5101
INJECTION, FILGRASTIM-SNDZ, BIOSIMILAR, (ZARXIO), 1 MICROGRAM
|
⇄
|
61314-0326-01
ZARXIO (PF) 480 MCG/0.8 ML
|
| Detail Information |
| Relationship Start Date |
05/04/2018 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
0.8 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SR |
| Route Of Administration |
IJ |
| Billing Units |
ML |
|
|
|
Q5101
Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram
|
⇄
|
61314-0326-05
ZARXIO 480 MCG/0.8 ML SYRINGE
|
| Detail Information |
| Relationship Start Date |
01/01/2025 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
0.8 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SYRINGE |
| Route Of Administration |
IJ |
| Billing Units |
ML |
|
|
|
Q5101
INJECTION, FILGRASTIM-SNDZ, BIOSIMILAR, (ZARXIO), 1 MICROGRAM
|
⇄
|
61314-0326-10
ZARXIO (PF) 480 MCG/0.8 ML
|
| Detail Information |
| Relationship Start Date |
07/20/2018 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
0.8 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SR |
| Route Of Administration |
IJ |
| Billing Units |
ML |
|
|
|
Q5101
Injection, zarxio
|
⇄
|
61314-0318-01
Zarxio
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q5101
Injection, zarxio
|
⇄
|
61314-0318-10
Zarxio
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q5101
Injection, zarxio
|
⇄
|
61314-0326-01
Zarxio
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q5101
Injection, zarxio
|
⇄
|
61314-0326-10
Zarxio
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|